GT199800053A - PHARMACEUTICAL COMPOSITIONS FOR THE ADMINISTRATION OF THE N-PIPERIDINE-5- (4-CHLOROPHENYL) -1- (2,4-DICHLOROPHENYL) -4-METHYLPIRAZOLE-3-CARBOXAMIDE, OF ITS SALES AND DESUSSOLVATES. - Google Patents
PHARMACEUTICAL COMPOSITIONS FOR THE ADMINISTRATION OF THE N-PIPERIDINE-5- (4-CHLOROPHENYL) -1- (2,4-DICHLOROPHENYL) -4-METHYLPIRAZOLE-3-CARBOXAMIDE, OF ITS SALES AND DESUSSOLVATES.Info
- Publication number
- GT199800053A GT199800053A GT199800053A GT199800053A GT199800053A GT 199800053 A GT199800053 A GT 199800053A GT 199800053 A GT199800053 A GT 199800053A GT 199800053 A GT199800053 A GT 199800053A GT 199800053 A GT199800053 A GT 199800053A
- Authority
- GT
- Guatemala
- Prior art keywords
- administration
- methylpirazole
- desussolvates
- dichlorophenyl
- carboxamide
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- -1 2,4-DICHLOROPHENYL Chemical class 0.000 title 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229940124531 pharmaceutical excipient Drugs 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 229910021653 sulphate ion Inorganic materials 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
COMPOSICION FARMACEUTICA PARA LA ADMINISTRACION ORAL DEL NPIPERIDINO5(4CLOROFENIL)1(2,4DICLOROFENIL)4METILPIRAZOLO3CARBOXAMIDA; O DE UNA DE SUS SALES FARMACEUTICAMENTE ACEPTABLES O DE UNO DE SUS SOLVATOS (EN ADELANTE PRINCIPIO ACTIVO), QUE COMPRENDE: 0.05% A 0.5% EN PESO DE UN ALQUILSULFATO DE SODIO, 2.5% A 10% EN PESO DE AGENTE DE DESAGREGACION, Y EXCIPIENTES FARMACEUTICOS.PHARMACEUTICAL COMPOSITION FOR THE ORAL ADMINISTRATION OF NPIPERIDINO5 (4CLOROFENIL) 1 (2,4DICLOROFENIL) 4METILPIRAZOLO3CARBOXAMIDA; OR OF ONE OF ITS PHARMACEUTICALLY ACCEPTABLE SALTS OR OF ONE OF ITS SOLVATES (IN ADVANCE ACTIVE SUBSTANCE), WHICH INCLUDES: 0.05% TO 0.5% BY WEIGHT OF A SODIUM ALKYL SULPHATE, 2.5% TO 10% BY WEIGHT OF DISAGGREGATION AGENT, AND PHARMACEUTICAL EXCIPIENTS.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GT199800053A GT199800053A (en) | 1998-03-26 | 1998-03-26 | PHARMACEUTICAL COMPOSITIONS FOR THE ADMINISTRATION OF THE N-PIPERIDINE-5- (4-CHLOROPHENYL) -1- (2,4-DICHLOROPHENYL) -4-METHYLPIRAZOLE-3-CARBOXAMIDE, OF ITS SALES AND DESUSSOLVATES. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GT199800053A GT199800053A (en) | 1998-03-26 | 1998-03-26 | PHARMACEUTICAL COMPOSITIONS FOR THE ADMINISTRATION OF THE N-PIPERIDINE-5- (4-CHLOROPHENYL) -1- (2,4-DICHLOROPHENYL) -4-METHYLPIRAZOLE-3-CARBOXAMIDE, OF ITS SALES AND DESUSSOLVATES. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT199800053A true GT199800053A (en) | 1999-09-17 |
Family
ID=47043828
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT199800053A GT199800053A (en) | 1998-03-26 | 1998-03-26 | PHARMACEUTICAL COMPOSITIONS FOR THE ADMINISTRATION OF THE N-PIPERIDINE-5- (4-CHLOROPHENYL) -1- (2,4-DICHLOROPHENYL) -4-METHYLPIRAZOLE-3-CARBOXAMIDE, OF ITS SALES AND DESUSSOLVATES. |
Country Status (1)
| Country | Link |
|---|---|
| GT (1) | GT199800053A (en) |
-
1998
- 1998-03-26 GT GT199800053A patent/GT199800053A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4950527A1 (en) | PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION OF N- PIPERIDINE-5- (4-CHLOROPHENYL) -1- (2,4-DICHLOROPHENYL) -4- METHYLPIRAZOLE-3-CARBOXAMIDE, ITS SALTS AND ITS SOLVATES | |
| PA8453201A1 (en) | PHARMACEUTICAL FORMULATIONS CONTAINING VORICONAZOLE | |
| ES2159591T3 (en) | COMPOSITION OF CONTROLLED RELEASE. | |
| DE60142891D1 (en) | AZETIDINE DERIVATIVES PHARMACEUTICAL COMPOSITIONS, THE AZETIDINE DERIVATIVES AND THEIR PREPARATION | |
| ATE260646T1 (en) | RAPID DISSOLVING ORAL DOSAGE FORM | |
| KR950007841A (en) | Sustained-release drug formulations containing tramadol salts | |
| MX9300664A (en) | PHARMACEUTICAL DOSAGE FORMS CONTAINING PROLONGED RELEASE OF ACTIVE INGREDIENT. | |
| CO5190672A1 (en) | COMPOSITION FOR ORAL DOSAGE, INSTANT DISSOLUTION | |
| BR0005938A (en) | Composition of oral dosage with prolonged release | |
| PA8548701A1 (en) | AZAINDOLS | |
| IT1271495B (en) | PHARMACEUTICAL COMPOSITION CONTAINING 3-2 (DIMETHYLAMINE) ETHYL-N-METHYL-1H-INDOL-5-METHANE SULPHONAMIDE, RELATIVE PROCEDURE FOR PREPARATION AND USE OF THE SAME IN TREATMENT OF MAMMALS | |
| ES2182357T3 (en) | NEW USE OF BUDESONIDE AND FORMOTEROL. | |
| BR0015605A (en) | Composition and use | |
| AR018197A1 (en) | PIPERIDINE COMPOUNDS, A PROCEDURE FOR THE PREPARATION, A COMPOSITION AND USE OF THE SAME FOR THE PREPARATION OF A MEDICINAL PRODUCT | |
| AR033688A1 (en) | RECONSTITUABLE PARENTERAL COMPOSITION | |
| ES2171440T3 (en) | SOLID COMPOSITION MUCOADHESIVA, THERAPEUTICS OR HYGIENIC, FOR ADMINISTRATION BY APPLICATION ON THE MUCOSA ORAL OR NASAL. | |
| SE0102843D0 (en) | Stabilized oral pharmaceutical composition containing lodide and lodate and method | |
| NO20034863L (en) | Deuterated 3-piperidinopropiophenone as well as drugs containing these compounds | |
| AP2003002763A0 (en) | Controlled release formulations for oral administration | |
| EA200001010A1 (en) | APPLICATION OF DEXMEDETOMIDINE FOR SEDATIVE IMPACT IN THE DEPARTMENT OF INTENSIVE THERAPY | |
| AR046036A1 (en) | RISEDRONATE COMPOSITIONS AND METHODS FOR USE | |
| PT92647A (en) | 5-CHLORO-2 - [((3,4-DIMETHOXY-2-PYRIDINYL) -METHYL) SULFINYL) -1H-BENZIMIDAZOLE AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING IT | |
| UY27539A1 (en) | PHARMACEUTICAL FORMULATION | |
| ES2175663T3 (en) | SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING MILTEPHOSINE FOR ORAL ADMINISTRATION IN THE TREATMENT OF LESHMANIASIS. | |
| LV10267A (en) | A compound for the purpose of obtaining a compound compound |